Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(5):319–325. doi: 10.1080/09629359890839

Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.

M Heuser 1, H van der Kuip 1, B Falini 1, C Peschel 1, C Huber 1, T Fischer 1
PMCID: PMC1781861  PMID: 9883966

Abstract

The physiological role of the pro-myelocytic leukaemia (PML) gene product is poorly defined. Among other functions, PML is involved in haematopoietic differentiation and in control of cell growth and tumorigenesis. We investigated the regulation of human PML expression by interferons (IFNs) and IL-1 in various human haematopoietic lines (U937, THP1, HL60, NB4), in human diploid fibroblasts and in human peripheral blood leukocytes. Cytokine-induced modulation of PML expression was assessed by Northern blot analyses, flow cytometry studies and in situ immunolabelling. Our data show that IFNs and IL-1 upregulate PML transcript and protein expression in a time and dose-dependent manner. In situ immunolabelling revealed that upregulation of protein expression by IFN-alpha is a consequence of a marked increase in both the number and the intensity of the staining of so-called PML nuclear bodies. Our data suggest that stimulation of PML expression by interferons and IL-1 may account for upregulation of PML proteins observed in inflammatory tissues and in proliferative states.

Full Text

The Full Text of this article is available as a PDF (539.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chelbi-Alix M. K., Pelicano L., Quignon F., Koken M. H., Venturini L., Stadler M., Pavlovic J., Degos L., de Thé H. Induction of the PML protein by interferons in normal and APL cells. Leukemia. 1995 Dec;9(12):2027–2033. [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Daniel M. T., Koken M., Romagné O., Barbey S., Bazarbachi A., Stadler M., Guillemin M. C., Degos L., Chomienne C., de Thé H. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 1993 Sep 15;82(6):1858–1867. [PubMed] [Google Scholar]
  4. David M., Romero G., Zhang Z. Y., Dixon J. E., Larner A. C. In vitro activation of the transcription factor ISGF3 by interferon alpha involves a membrane-associated tyrosine phosphatase and tyrosine kinase. J Biol Chem. 1993 Mar 25;268(9):6593–6599. [PubMed] [Google Scholar]
  5. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  6. Fagioli M., Alcalay M., Pandolfi P. P., Venturini L., Mencarelli A., Simeone A., Acampora D., Grignani F., Pelicci P. G. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene. 1992 Jun;7(6):1083–1091. [PubMed] [Google Scholar]
  7. Fischer T., Wiegmann K., Böttinger H., Morens K., Burmester G., Pfizenmaier K. Regulation of IFN-gamma-receptor expression in human monocytes by granulocyte-macrophage colony-stimulating factor. J Immunol. 1990 Nov 1;145(9):2914–2919. [PubMed] [Google Scholar]
  8. Flenghi L., Fagioli M., Tomassoni L., Pileri S., Gambacorta M., Pacini R., Grignani F., Casini T., Ferrucci P. F., Martelli M. F. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood. 1995 Apr 1;85(7):1871–1880. [PubMed] [Google Scholar]
  9. Gambacorta M., Flenghi L., Fagioli M., Pileri S., Leoncini L., Bigerna B., Pacini R., Tanci L. N., Pasqualucci L., Ascani S. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol. 1996 Dec;149(6):2023–2035. [PMC free article] [PubMed] [Google Scholar]
  10. Goddard A. D., Borrow J., Freemont P. S., Solomon E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 1991 Nov 29;254(5036):1371–1374. doi: 10.1126/science.1720570. [DOI] [PubMed] [Google Scholar]
  11. Grignani F., Ferrucci P. F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschle C., Nicoletti I. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 1993 Aug 13;74(3):423–431. doi: 10.1016/0092-8674(93)80044-f. [DOI] [PubMed] [Google Scholar]
  12. Kakizuka A., Miller W. H., Jr, Umesono K., Warrell R. P., Jr, Frankel S. R., Murty V. V., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 1991 Aug 23;66(4):663–674. doi: 10.1016/0092-8674(91)90112-c. [DOI] [PubMed] [Google Scholar]
  13. Koken M. H., Linares-Cruz G., Quignon F., Viron A., Chelbi-Alix M. K., Sobczak-Thépot J., Juhlin L., Degos L., Calvo F., de Thé H. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 1995 Apr 6;10(7):1315–1324. [PubMed] [Google Scholar]
  14. Lavau C., Marchio A., Fagioli M., Jansen J., Falini B., Lebon P., Grosveld F., Pandolfi P. P., Pelicci P. G., Dejean A. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene. 1995 Sep 7;11(5):871–876. [PubMed] [Google Scholar]
  15. Mu Z. M., Chin K. V., Liu J. H., Lozano G., Chang K. S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol. 1994 Oct;14(10):6858–6867. doi: 10.1128/mcb.14.10.6858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ransohoff R. M. Cellular responses to interferons and other cytokines: the JAK-STAT paradigm. N Engl J Med. 1998 Feb 26;338(9):616–618. doi: 10.1056/NEJM199802263380911. [DOI] [PubMed] [Google Scholar]
  17. Sen G. C., Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem. 1992 Mar 15;267(8):5017–5020. [PubMed] [Google Scholar]
  18. Stadler M., Chelbi-Alix M. K., Koken M. H., Venturini L., Lee C., Saïb A., Quignon F., Pelicano L., Guillemin M. C., Schindler C. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene. 1995 Dec 21;11(12):2565–2573. [PubMed] [Google Scholar]
  19. Terris B., Baldin V., Dubois S., Degott C., Flejou J. F., Hénin D., Dejean A. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 1995 Apr 1;55(7):1590–1597. [PubMed] [Google Scholar]
  20. Visa N., Puvion-Dutilleul F., Harper F., Bachellerie J. P., Puvion E. Intranuclear distribution of poly(A) RNA determined by electron microscope in situ hybridization. Exp Cell Res. 1993 Sep;208(1):19–34. doi: 10.1006/excr.1993.1218. [DOI] [PubMed] [Google Scholar]
  21. Wang Z. G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., Grosveld F., Pandolfi P. P. Role of PML in cell growth and the retinoic acid pathway. Science. 1998 Mar 6;279(5356):1547–1551. doi: 10.1126/science.279.5356.1547. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES